Intellia Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2015 | — | $-1.2M | $-1.1M |
| Jun 2015 | — | $-3.4M | $-3.0M |
| Sep 2015 | — | $-3.3M | $-3.0M |
| Dec 2015 | — | $-5.5M | $-5.2M |
| Mar 2016 | — | $-6.7M | $-6.7M |
| Jun 2016 | — | $-6.9M | $-6.9M |
| Sep 2016 | — | $-7.7M | $-7.5M |
| Dec 2016 | — | $-10.8M | $-10.6M |
| Mar 2017 | $6.2M | $-12.9M | $-12.6M |
| Jun 2017 | $5.9M | $-16.0M | $-15.6M |
| Sep 2017 | $7.3M | $-15.9M | $-15.4M |
| Dec 2017 | $6.7M | $-24.7M | $-24.0M |
| Mar 2018 | $7.5M | $-22.4M | $-21.4M |
| Jun 2018 | $7.7M | $-23.6M | $-22.2M |
| Sep 2018 | $7.4M | $-24.1M | $-22.7M |
| Dec 2018 | $7.9M | $-20.7M | $-19.1M |
| Mar 2019 | $10.4M | $-23.8M | $-21.9M |
| Jun 2019 | $11.1M | $-27.5M | $-25.7M |
| Sep 2019 | $10.6M | $-25.3M | $-23.6M |
| Dec 2019 | $10.9M | $-29.8M | $-28.3M |
| Mar 2020 | $12.9M | $-33.0M | $-31.8M |
| Jun 2020 | $16.3M | $-33.0M | $-32.4M |
| Sep 2020 | $22.2M | $-28.1M | $-27.8M |
| Dec 2020 | $6.6M | $-42.4M | $-42.2M |
| Mar 2021 | $6.4M | $-46.4M | $-46.2M |
| Jun 2021 | $6.6M | $-69.0M | $-68.8M |
| Sep 2021 | $7.2M | $-72.0M | $-71.6M |
| Dec 2021 | $12.9M | $-80.4M | $-81.2M |
| Mar 2022 | $11.3M | $-144.2M | $-146.9M |
| Jun 2022 | $14.0M | $-98.3M | $-100.7M |
| Sep 2022 | $13.3M | $-105.5M | $-113.2M |
| Dec 2022 | $13.6M | $-110.1M | $-113.4M |
| Mar 2023 | $12.6M | $-112.0M | $-103.1M |
| Jun 2023 | $13.6M | $-132.3M | $-123.7M |
| Sep 2023 | $12.0M | $-131.1M | $-122.2M |
| Dec 2023 | $-1.9M | $-139.9M | $-132.2M |
| Mar 2024 | $28.9M | $-114.0M | $-107.4M |
| Jun 2024 | $7.0M | $-139.0M | $-147.0M |
| Sep 2024 | $9.1M | $-144.8M | $-135.7M |
| Dec 2024 | $12.9M | $-136.4M | $-128.9M |
| Mar 2025 | $16.6M | $-120.8M | $-114.3M |
| Jun 2025 | $14.2M | $-110.0M | $-101.3M |
| Sep 2025 | $13.8M | $-111.5M | $-101.3M |
| Dec 2025 | $23.0M | $-98.7M | $-95.8M |
| Mar 2026 | $15.0M | $-100.5M | $-96.2M |
| Jun 2026 | $7.7M | $-112.8M | $-106.6M |